MedTrace Logo

Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention

NCT01528007 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-12-05

No results posted yet for this study

Summary

The aim of this research is to explore the efficacy of the opiate antagonist, naltrexone as combined with CBT-intervention in the treatment of pathological gambling (PG). The study period is 2011-2014 during which one hundred Pathological Gamblers will be recruited to participate to this placebo-controlled double-blind trial.

Conditions

  • Pathological Gambling

Interventions

DRUG

Naltrexone pharmacotherapy

Naltrexone 50mg when graving to gamble.

DRUG

Placebo

Placebo pill with no active ingredients.

Sponsors & Collaborators

  • Finnish Institute for Health and Welfare

    lead OTHER_GOV

Principal Investigators

  • Hannu Alho, Professor · Finnish Institute for Health and Welfare

  • Tuuli Lahti, Adjunct Professor · Finnish Institute for Health and Welfare

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01528007 on ClinicalTrials.gov